Form 8-K - Current report:
SEC Accession No. 0000950170-25-101620
Filing Date
2025-08-04
Accepted
2025-08-04 07:35:30
Documents
12
Period of Report
2025-08-04
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K dyn-20250804.htm   iXBRL 8-K 59926
2 EX-99.1 dyn-ex99_1.htm EX-99.1 32460
3 GRAPHIC img259164492_0.jpg GRAPHIC 103686
  Complete submission text file 0000950170-25-101620.txt   353952

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dyn-20250804.xsd EX-101.SCH 30687
14 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20250804_htm.xml XML 4521
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)